The daily business briefing: July 23, 2020
The U.S. orders 100 million doses of Pfizer vaccine, Tesla reports its fourth straight quarterly profit, and more

1. Government orders 100 million doses of Pfizer, BioNTech vaccine
Pfizer and BioNTech on Wednesday announced that the federal government had placed a nearly $2 billion order for 100 million doses of their potential COVID-19 vaccine. The U.S. will be able to order up to another 500 million doses after the drug receives approval or authorization from the Food and Drug Administration. On Wednesday, Pfizer and BioNTech said that depending on how studies of the vaccine go, they aim to "be ready to seek Emergency Use Authorization or some form of regulatory approval as early as October 2020." If that goes forward, they'll look to manufacture up to 100 million doses globally by the end of the year and "potentially more than 1.3 billion doses by the end of 2021." Pfizer shares rose by 5 percent after the announcement, and BioNTech's U.S.-listed shares jumped by nearly 14 percent.
2. Tesla posts 4th straight quarterly profit
Tesla shares rose 4 percent in after-hours trading Wednesday after the company beat expectations, reporting its fourth straight profitable quarter. Tesla also announced Wednesday that it had selected the Austin, Texas, area as the future home of the electric-car maker's biggest assembly plant. The new factory will employ at least 5,000 workers and build Tesla's new Cybertruck pickup. It also will become the company's second production facility for the Model Y small SUV. Tesla will receive more than $60 million in tax breaks to build the factory on a 2,100-acre site near Austin. The company has promised to invest $1.1 billion in the facility, and pay workers at least $15 an hour plus health insurance and other benefits. Tesla CEO Elon Musk's SpaceX rocket company also has operations in Texas.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Stock futures edge higher with focus on corporate earnings
U.S. stock index futures gained early Thursday as investors continued to focus on corporate earnings reports. Futures for the Dow Jones Industrial Average and the S&P 500 were up by about 0.4 percent several hours before the opening bell. The Nasdaq rose by about 0.8 percent. Software giant Microsoft fell by as much as 3 percent in after-hours trading after problems at its subsidiary LinkedIn due to the coronavirus crisis' impact on the job market. Tesla shares rose sharply after the electric-car maker reported its fourth straight quarterly profit. The three main U.S. indexes all closed higher on Wednesday with a boost from positive news on a COVID-19 vaccine, and apparent progress on Capitol Hill toward a new coronavirus relief bill.
4. United: Revenue won't rise over half of pre-pandemic level without vaccine
United Airlines executives said Wednesday that they expected air travel demand to increase once the number of new coronavirus infections starts dropping, but that their revenue would not rise above 50 percent of pre-pandemic levels until a vaccine was available. United reported this week that its revenue plummeted by 89 percent in the second quarter as the pandemic decimated the travel industry, resulting in a $1.6 billion loss. Air travel had started recovering but fell again when coronavirus cases started spiking in the South and West in late June. About 530,000 people passed through U.S. airport security checkpoints on Tuesday, a drop of 78 percent from the traffic level a year earlier.
5. Unilever sales fall less than expected
Consumer goods giant Unilever reported that its second-quarter sales fell by less than expected as coronavirus lockdowns forced people to eat at home more, increasing demand for such products as Knorr soups and Breyers ice cream. The Anglo-Dutch company's sales fell by 0.3 percent in the three months that ended June 30. Analysts on average had forecast a 4.3 percent drop due to shutdowns of restaurants, schools, movie theaters, and other outlets offering the company's goods. Unilever shares surged by as much as 8.7 percent early Thursday after the company released its results. Despite the good news, the sales decline was the company's first since the third quarter in 2004, according to Jefferies analysts.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
A running list of RFK Jr.'s controversies
In Depth The man atop the Department of Health and Human Services has had no shortage of scandals over the years
By Brigid Kennedy
-
Film reviews: Sinners and The King of Kings
Feature Vampires lay siege to a Mississippi juke joint and an animated retelling of Jesus' life
By The Week US
-
Music reviews: Bon Iver, Valerie June, and The Waterboys
Feature "Sable, Fable," "Owls, Omens, and Oracles," "Life, Death, and Dennis Hopper"
By The Week US
-
Why Russia removed the Taliban's terrorist designation
The Explainer Russia had designated the Taliban as a terrorist group over 20 years ago
By Justin Klawans, The Week US
-
Inside the Israel-Turkey geopolitical dance across Syria
THE EXPLAINER As Syria struggles in the wake of the Assad regime's collapse, its neighbors are carefully coordinating to avoid potential military confrontations
By Rafi Schwartz, The Week US
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
By Abby Wilson
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
By Justin Klawans, The Week US
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical
By The Week Staff
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK